|
2025
|
G/S
|
Antioxidants for medical purposes, namely, antioxidants for use in the manufacture of pharmaceuti... |
|
2024
|
Invention
|
Platform drug delivery system utilizing crystal engineering and theanine dissolution.
A platform... |
|
|
Invention
|
Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and met... |
|
2022
|
Invention
|
Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, so... |
|
|
G/S
|
Antipyretic, analgesic, anti-inflammatory preparations;
antioxidants for medical purposes; prepa... |
|
|
Invention
|
Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stre... |
|
2021
|
Invention
|
Platform drug delivery system utilizing crystal engineering and theanine dissolution. A platform ... |
|
2016
|
Invention
|
Characterization of the cocrystal products formed by metoprolol and dabigatran bases with l-thean... |
|
|
Invention
|
Platform drug delivery system utilizing crystal engineering and theanine dissolution. A method of... |
|
2014
|
Invention
|
Adjuvant to thrombolytic therapy for the treatment of frostbite.
A method of treating frostbite ... |
|
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine. A met... |
|
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine.
A me... |
|
2012
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine.
A wa... |
|
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine. An as... |
|
2009
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine.
|
|
|
Invention
|
Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine. A wat... |
